Inhibition of Cardiac Ca2+ Release Channels (RyR2) Determines Efficacy of Class I Antiarrhythmic Drugs in Catecholaminergic Polymorphic Ventricular Tachycardia

Circulation: Arrhythmia and Electrophysiology - United States
doi 10.1161/circep.110.959916
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Catecholaminergic Polymorphic Ventricular Tachycardia

2020English

Catecholaminergic Polymorphic Ventricular Tachycardia in 2012

Cardiogenetics
2011English

Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Efficacy of Bilateral Thoracoscopic Sympathectomy in a Patient With Catecholaminergic Polymorphic Ventricular Tachycardia

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2016English

Postexertional Supraventricular Tachycardia in Children With Catecholaminergic Polymorphic Ventricular Tachycardia

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2012English

New Data on Catecholaminergic Polymorphic Ventricular Tachycardia in Japan

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Cardiac Outcomes During Pregnant and Non-Pregnant Periods in Catecholaminergic Polymorphic Ventricular Tachycardia

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Search for Cardiac Calcium Cycling Gene Mutations in Familial Ventricular Arrhythmias Resembling Catecholaminergic Polymorphic Ventricular Tachycardia

BMC Medical Genetics
Genetics
2009English

A Novel Heterozygous Mutation in Cardiac Calsequestrin Causes Autosomal Dominant Catecholaminergic Polymorphic Ventricular Tachycardia

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy